Evidence
Real-World Evidence: rtCGM Prevents Glycemic Deterioration in Well-Controlled, Insulin-Treated Type 2 Diabetes
June 11, 2022Clinical Outcomes Article / Publication
In a retrospective claims analysis from Kaiser Permanente of Northern California, 149 patients with insulin-treated type 2 diabetes (T2D; baseline HbA1c <8%) who initiated real-time continuous glucose monitoring (RT-CGM) demonstrated durable glycemic benefit compared with 17,273 noninitiators serving as reference. RT-CGM initiation was associated with decreased HbA1c (-0.06%) while noninitiation was associated with increased HbA1c (+0.32%). A weighted adjusted difference-in-difference model of change in HbA1c yielded a net benefit of -0.30% (P=0.004) for RT-CGM. These findings highlight the notion that RT-CGM may be useful in preventing glycemic deterioration and offer a durable benefit in well-controlled patients with insulin-treated T2D.
Karter AJ, Parker MM, Moffet HH, Gilliam LK, Dlott R. Continuous Glucose Monitor Use Prevents Glycemic Deterioration in Insulin-Treated Patients with Type 2 Diabetes. Diabetes Technol Ther. 2022;24(5):332-337.
Learn MoreMay 19, 2022Coverage and Benefit Design Video
The American Diabetes Association (ADA) Standards of Medical Care represent the latest evidence-based recommendations for guiding clinical practice. According to the most recent edition of these guidelines, Level A evidence from the MOBILE study supports the use of real time continuous glucose monitoring (rtCGM) in patients with insulin-treated type 2 diabetes (T2D) regardless of regimen. The findings from the MOBILE study likewise demonstrate the value of rtCGM across typically underserved demographics of patients impacted by social determinants of health (SDOH). Taking the ADA recommendations into consideration, payers are formulating coverage policies that facilitate appropriate access to rtCGM, improved outcomes in T2D, and proven per-member-per-month (PMPM) cost savings.
Video Summary
Continuous Glucose Monitoring: Using New Evidence and Digital Innovations to Optimize Diabetes Care Management
April 28, 2022CGM Technology and Digital Health Webinar / Archive
Source: AMCP Science and Innovation Theater Webinar – February 16, 2022
Key Takeaway:
The Dexcom CGM system is unique with the ability to connect with multiple digital health solutions. Combining CGM with digital health apps allows users to quickly see all their data in one place. Access to real-time data can empower people with diabetes and foster patient engagement with in-the-moment diabetes feedback and the opportunity for coaching.
The recently updated American Diabetes Association (ADA) Standards of Care (SOC) 20221 revised the technology recommendations focusing on use of continuous glucose monitoring (CGM). In addition, the ADA added digital health to the recommendations noting the opportunity for digital coaching as a tool for education. Join this webinar for a deep dive into the updated CGM technology SOC and learn about the current evidence that influenced recent changes. Diabetes technology is evolving rapidly, stay up to date with CGM to enhance your knowledge.
1. American Diabetes Association. Diabetes Care. 2022;45(Suppl1):S97-S112
Learn MoreMarch 10, 2022Population Health Article / Publication
In 2021, NCQA and HL7 hosted the fifth annual Digital Quality Summit (DQS) that convened stakeholders within six distinct “tracks” – each track exploring a different subset of healthcare. Track 6 of the Digital Quality Summit featured five breakout sessions that covered topics such as Continuous Glucose Monitoring (CGM), diabetes distress, digital measurement and measure concepts related to diabetes care, optimal care for individuals with type 1 and type 2 diabetes, NCQA’s own Diabetes Recognition Program, and more.
The Rethinking Diabetes Care in the Digital Age white paper contains findings from track 6 of the Digital Quality Summit and is broken down into the following sections:
1. Importance of Measurement in Diabetes Care beyond HbA1c and Depression
2. Optimal Diabetes Care Management and Continuous Glucose Monitoring
3. Behavioral Aspects in Diabetes Care and Diabetes Distress
4. Health Equity in Diabetes Care Management
5. Driving Improvements in Diabetes Care and the Diabetes Recognition Program
Learn MoreMarch 9, 2022Coverage and Benefit Design Guidelines / Policy
Source: Center for Health Care Strategies
Published: January 2022
LEARN MOREClinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: A systematic literature review
March 8, 2022Clinical Outcomes Economic Outcomes Article / PublicationLearn MoreFebruary 3, 2022Clinical Outcomes Coverage and Benefit Design Infographic
Payer Insights Infographic
Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study
January 12, 2022Clinical Outcomes Article / PublicationLearn MoreJanuary 4, 2022Clinical Outcomes Featured News & Info Video
Sign Up To Stay Current On The Latest Coverage
Updates, Recent News, And Resources
Real-World Evidence: rtCGM Prevents Glycemic Deterioration in Well-Controlled, Insulin-Treated Type 2 Diabetes
In a retrospective claims analysis from Kaiser Permanente of Northern California, 149 patients with insulin-treated type 2 diabetes (T2D; baseline HbA1c <8%) who initiated real-time continuous glucose monitoring (RT-CGM) demonstrated durable glycemic benefit compared with 17,273 noninitiators serving as reference. RT-CGM initiation was associated with decreased HbA1c (-0.06%) while noninitiation was associated with increased HbA1c (+0.32%). A weighted adjusted difference-in-difference model of change in HbA1c yielded a net benefit of -0.30% (P=0.004) for RT-CGM. These findings highlight the notion that RT-CGM may be useful in preventing glycemic deterioration and offer a durable benefit in well-controlled patients with insulin-treated T2D.
Karter AJ, Parker MM, Moffet HH, Gilliam LK, Dlott R. Continuous Glucose Monitor Use Prevents Glycemic Deterioration in Insulin-Treated Patients with Type 2 Diabetes. Diabetes Technol Ther. 2022;24(5):332-337.
Learn MoreMay 19, 2022Coverage and Benefit Design Video
The American Diabetes Association (ADA) Standards of Medical Care represent the latest evidence-based recommendations for guiding clinical practice. According to the most recent edition of these guidelines, Level A evidence from the MOBILE study supports the use of real time continuous glucose monitoring (rtCGM) in patients with insulin-treated type 2 diabetes (T2D) regardless of regimen. The findings from the MOBILE study likewise demonstrate the value of rtCGM across typically underserved demographics of patients impacted by social determinants of health (SDOH). Taking the ADA recommendations into consideration, payers are formulating coverage policies that facilitate appropriate access to rtCGM, improved outcomes in T2D, and proven per-member-per-month (PMPM) cost savings.
Video Summary
Continuous Glucose Monitoring: Using New Evidence and Digital Innovations to Optimize Diabetes Care Management
April 28, 2022CGM Technology and Digital Health Webinar / Archive
Source: AMCP Science and Innovation Theater Webinar – February 16, 2022
Key Takeaway:
The Dexcom CGM system is unique with the ability to connect with multiple digital health solutions. Combining CGM with digital health apps allows users to quickly see all their data in one place. Access to real-time data can empower people with diabetes and foster patient engagement with in-the-moment diabetes feedback and the opportunity for coaching.
The recently updated American Diabetes Association (ADA) Standards of Care (SOC) 20221 revised the technology recommendations focusing on use of continuous glucose monitoring (CGM). In addition, the ADA added digital health to the recommendations noting the opportunity for digital coaching as a tool for education. Join this webinar for a deep dive into the updated CGM technology SOC and learn about the current evidence that influenced recent changes. Diabetes technology is evolving rapidly, stay up to date with CGM to enhance your knowledge.
1. American Diabetes Association. Diabetes Care. 2022;45(Suppl1):S97-S112
Learn MoreMarch 10, 2022Population Health Article / Publication
In 2021, NCQA and HL7 hosted the fifth annual Digital Quality Summit (DQS) that convened stakeholders within six distinct “tracks” – each track exploring a different subset of healthcare. Track 6 of the Digital Quality Summit featured five breakout sessions that covered topics such as Continuous Glucose Monitoring (CGM), diabetes distress, digital measurement and measure concepts related to diabetes care, optimal care for individuals with type 1 and type 2 diabetes, NCQA’s own Diabetes Recognition Program, and more.
The Rethinking Diabetes Care in the Digital Age white paper contains findings from track 6 of the Digital Quality Summit and is broken down into the following sections:
1. Importance of Measurement in Diabetes Care beyond HbA1c and Depression
2. Optimal Diabetes Care Management and Continuous Glucose Monitoring
3. Behavioral Aspects in Diabetes Care and Diabetes Distress
4. Health Equity in Diabetes Care Management
5. Driving Improvements in Diabetes Care and the Diabetes Recognition Program
Learn MoreMarch 9, 2022Coverage and Benefit Design Guidelines / Policy
Source: Center for Health Care Strategies
Published: January 2022
LEARN MOREClinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: A systematic literature review
March 8, 2022Clinical Outcomes Economic Outcomes Article / PublicationLearn MoreFebruary 3, 2022Clinical Outcomes Coverage and Benefit Design Infographic
Payer Insights Infographic
Learn More
Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study
January 12, 2022Clinical Outcomes Article / PublicationLearn MoreJanuary 4, 2022Clinical Outcomes Featured News & Info Video
Sign Up To Stay Current On The Latest Coverage
Updates, Recent News, And Resources
The American Diabetes Association (ADA) Standards of Medical Care represent the latest evidence-based recommendations for guiding clinical practice. According to the most recent edition of these guidelines, Level A evidence from the MOBILE study supports the use of real time continuous glucose monitoring (rtCGM) in patients with insulin-treated type 2 diabetes (T2D) regardless of regimen. The findings from the MOBILE study likewise demonstrate the value of rtCGM across typically underserved demographics of patients impacted by social determinants of health (SDOH). Taking the ADA recommendations into consideration, payers are formulating coverage policies that facilitate appropriate access to rtCGM, improved outcomes in T2D, and proven per-member-per-month (PMPM) cost savings.
Video Summary
Continuous Glucose Monitoring: Using New Evidence and Digital Innovations to Optimize Diabetes Care Management
April 28, 2022CGM Technology and Digital Health Webinar / Archive
Source: AMCP Science and Innovation Theater Webinar – February 16, 2022
Key Takeaway:
The Dexcom CGM system is unique with the ability to connect with multiple digital health solutions. Combining CGM with digital health apps allows users to quickly see all their data in one place. Access to real-time data can empower people with diabetes and foster patient engagement with in-the-moment diabetes feedback and the opportunity for coaching.
The recently updated American Diabetes Association (ADA) Standards of Care (SOC) 20221 revised the technology recommendations focusing on use of continuous glucose monitoring (CGM). In addition, the ADA added digital health to the recommendations noting the opportunity for digital coaching as a tool for education. Join this webinar for a deep dive into the updated CGM technology SOC and learn about the current evidence that influenced recent changes. Diabetes technology is evolving rapidly, stay up to date with CGM to enhance your knowledge.
1. American Diabetes Association. Diabetes Care. 2022;45(Suppl1):S97-S112
Learn MoreMarch 10, 2022Population Health Article / Publication
In 2021, NCQA and HL7 hosted the fifth annual Digital Quality Summit (DQS) that convened stakeholders within six distinct “tracks” – each track exploring a different subset of healthcare. Track 6 of the Digital Quality Summit featured five breakout sessions that covered topics such as Continuous Glucose Monitoring (CGM), diabetes distress, digital measurement and measure concepts related to diabetes care, optimal care for individuals with type 1 and type 2 diabetes, NCQA’s own Diabetes Recognition Program, and more.
The Rethinking Diabetes Care in the Digital Age white paper contains findings from track 6 of the Digital Quality Summit and is broken down into the following sections:
1. Importance of Measurement in Diabetes Care beyond HbA1c and Depression
2. Optimal Diabetes Care Management and Continuous Glucose Monitoring
3. Behavioral Aspects in Diabetes Care and Diabetes Distress
4. Health Equity in Diabetes Care Management
5. Driving Improvements in Diabetes Care and the Diabetes Recognition Program
Learn MoreMarch 9, 2022Coverage and Benefit Design Guidelines / Policy
Source: Center for Health Care Strategies
Published: January 2022
LEARN MOREClinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: A systematic literature review
March 8, 2022Clinical Outcomes Economic Outcomes Article / PublicationLearn MoreFebruary 3, 2022Clinical Outcomes Coverage and Benefit Design Infographic
Payer Insights Infographic
Learn More
Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study
January 12, 2022Clinical Outcomes Article / PublicationLearn MoreJanuary 4, 2022Clinical Outcomes Featured News & Info Video
Sign Up To Stay Current On The Latest Coverage
Updates, Recent News, And Resources
Continuous Glucose Monitoring: Using New Evidence and Digital Innovations to Optimize Diabetes Care Management
Source: AMCP Science and Innovation Theater Webinar – February 16, 2022
Key Takeaway:
The Dexcom CGM system is unique with the ability to connect with multiple digital health solutions. Combining CGM with digital health apps allows users to quickly see all their data in one place. Access to real-time data can empower people with diabetes and foster patient engagement with in-the-moment diabetes feedback and the opportunity for coaching.
The recently updated American Diabetes Association (ADA) Standards of Care (SOC) 20221 revised the technology recommendations focusing on use of continuous glucose monitoring (CGM). In addition, the ADA added digital health to the recommendations noting the opportunity for digital coaching as a tool for education. Join this webinar for a deep dive into the updated CGM technology SOC and learn about the current evidence that influenced recent changes. Diabetes technology is evolving rapidly, stay up to date with CGM to enhance your knowledge.
1. American Diabetes Association. Diabetes Care. 2022;45(Suppl1):S97-S112
Learn MoreMarch 10, 2022Population Health Article / Publication
In 2021, NCQA and HL7 hosted the fifth annual Digital Quality Summit (DQS) that convened stakeholders within six distinct “tracks” – each track exploring a different subset of healthcare. Track 6 of the Digital Quality Summit featured five breakout sessions that covered topics such as Continuous Glucose Monitoring (CGM), diabetes distress, digital measurement and measure concepts related to diabetes care, optimal care for individuals with type 1 and type 2 diabetes, NCQA’s own Diabetes Recognition Program, and more.
The Rethinking Diabetes Care in the Digital Age white paper contains findings from track 6 of the Digital Quality Summit and is broken down into the following sections:
1. Importance of Measurement in Diabetes Care beyond HbA1c and Depression
2. Optimal Diabetes Care Management and Continuous Glucose Monitoring
3. Behavioral Aspects in Diabetes Care and Diabetes Distress
4. Health Equity in Diabetes Care Management
5. Driving Improvements in Diabetes Care and the Diabetes Recognition Program
Learn MoreMarch 9, 2022Coverage and Benefit Design Guidelines / Policy
Source: Center for Health Care Strategies
Published: January 2022
LEARN MOREClinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: A systematic literature review
March 8, 2022Clinical Outcomes Economic Outcomes Article / PublicationLearn MoreFebruary 3, 2022Clinical Outcomes Coverage and Benefit Design Infographic
Payer Insights Infographic
Learn More
Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study
January 12, 2022Clinical Outcomes Article / PublicationLearn MoreJanuary 4, 2022Clinical Outcomes Featured News & Info Video
Sign Up To Stay Current On The Latest Coverage
Updates, Recent News, And Resources
In 2021, NCQA and HL7 hosted the fifth annual Digital Quality Summit (DQS) that convened stakeholders within six distinct “tracks” – each track exploring a different subset of healthcare. Track 6 of the Digital Quality Summit featured five breakout sessions that covered topics such as Continuous Glucose Monitoring (CGM), diabetes distress, digital measurement and measure concepts related to diabetes care, optimal care for individuals with type 1 and type 2 diabetes, NCQA’s own Diabetes Recognition Program, and more.
The Rethinking Diabetes Care in the Digital Age white paper contains findings from track 6 of the Digital Quality Summit and is broken down into the following sections:
1. Importance of Measurement in Diabetes Care beyond HbA1c and Depression
2. Optimal Diabetes Care Management and Continuous Glucose Monitoring
3. Behavioral Aspects in Diabetes Care and Diabetes Distress
4. Health Equity in Diabetes Care Management
5. Driving Improvements in Diabetes Care and the Diabetes Recognition Program
Learn MoreMarch 9, 2022Coverage and Benefit Design Guidelines / Policy
Source: Center for Health Care Strategies
Published: January 2022
LEARN MOREClinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: A systematic literature review
March 8, 2022Clinical Outcomes Economic Outcomes Article / PublicationLearn MoreFebruary 3, 2022Clinical Outcomes Coverage and Benefit Design Infographic
Payer Insights Infographic
Learn More
Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study
January 12, 2022Clinical Outcomes Article / PublicationLearn MoreJanuary 4, 2022Clinical Outcomes Featured News & Info Video
Sign Up To Stay Current On The Latest Coverage
Updates, Recent News, And Resources
Source: Center for Health Care Strategies
Published: January 2022
LEARN MOREClinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: A systematic literature review
March 8, 2022Clinical Outcomes Economic Outcomes Article / PublicationLearn MoreFebruary 3, 2022Clinical Outcomes Coverage and Benefit Design Infographic
Payer Insights Infographic
Learn More
Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study
January 12, 2022Clinical Outcomes Article / PublicationLearn MoreJanuary 4, 2022Clinical Outcomes Featured News & Info Video
Sign Up To Stay Current On The Latest Coverage
Updates, Recent News, And Resources
Clinical and economic outcomes of continuous glucose monitoring system (CGMS) in patients with diabetes mellitus: A systematic literature review
February 3, 2022Clinical Outcomes Coverage and Benefit Design Infographic
Payer Insights Infographic
Learn More
Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study
January 12, 2022Clinical Outcomes Article / PublicationLearn MoreJanuary 4, 2022Clinical Outcomes Featured News & Info Video
Sign Up To Stay Current On The Latest Coverage
Updates, Recent News, And Resources
Payer Insights Infographic
Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study
January 12, 2022Clinical Outcomes Article / PublicationLearn MoreJanuary 4, 2022Clinical Outcomes Featured News & Info Video
Sign Up To Stay Current On The Latest Coverage
Updates, Recent News, And Resources
